Vocal Biomarkers Market Size, Industry Analysis Report,
Regional Outlook & Forecast,2017-2024: Global Market
Insights Inc.
Vocal Biomarkers Market size witness significant growth due to increased prevalence of
cardiovascular and psychological diseases over the last few years. Growing demand for
minimally invasive procedures from patients coupled with fast recovery should fuel the
global vocal biomarkers market size during the forecast period.
Sound vibrations are used as therapeutic healing for mental health conditions which
includes depression, nervousness, and coronary artery disease. Ongoing research has
significantly widened its application in disease diagnosis. Health Insurance Portability
and Accountability Act (HIPAA) compliant vocal biomarker system may serve as
effective technique due to the successful completion of clinical trials. It serves as an
alternative to existing diagnostic technique such as CT scan, MRI and X-Ray. High cost
associated with these tests may result into burden for governments and insurance
companies eventually leading to hamper the business growth.
Continuous research to identify vocal biomarkers in diagnosis of Parkinson’s disease,
cognitive impairment, respiratory diseases, and traumatic brain injury will provide
highly lucrative growth opportunities for industry players. The technology is user-
friendly and offers self-diagnosis and medication. As per the WHO 2016 data, nearly 350
million individuals were suffering from depression. According to the Parkinson’s
disease Foundation 2016, around 10 million individuals were suffering with Parkinson’s
disease across the world. Growing global disease prevalence will drive vocal biomarkers
market size in the coming years.
Growing prevalence of respiratory diseases such as asthma should drive industry
growth. As per European Respiratory Society, over 235 million people suffer from
asthma across the world in 2016. Psychiatric and medical diagnosis can be more precise
when access to huge amount of biological and psychological data and speech feature is
recorded. Mayo Clinic in Minnesota is tracking vocal biomarkers to enhance remote
health monitoring of patients with heart disease. Clinic is working with Israeli company
Beyond Verbal to test the voice of patients with coronary artery disease. Health insurers
will contribute for lucrative growth. Humana, Blue Cross Blue Shield Association, and
Aetna are using vocal biomarkers to identify stress and depression among callers.
1 | Page